tiprankstipranks
Trending News
More News >
Tamar Petroleum Ltd. (IL:TMRP)
:TMRP
Israel Market

Tamar Pet (TMRP) AI Stock Analysis

Compare
3 Followers

Top Page

IL:TMRP

Tamar Pet

(TMRP)

Select Model
Select Model
Select Model
Neutral 65 (OpenAI - 5.2)
Rating:65Neutral
Price Target:
3,588.00
▼(-15.58% Downside)
Tamar Pet's overall score is driven by strong cash flow generation and a healthy dividend yield, offset by high leverage and bearish technical indicators. The lack of earnings call data and corporate events means these factors did not influence the score.
Positive Factors
Strong free cash flow conversion
Sizable FCF growth and efficient cash conversion indicate the business reliably turns earnings into cash. This supports sustainable reinvestment, debt servicing and dividends over the medium term, reducing refinancing risk and enabling strategic flexibility.
High operating profitability
Elevated EBIT and EBITDA margins reflect durable operational efficiency and cost structure advantages. High margins provide margin of safety against input cost inflation and competitive pricing pressure, supporting long-term cash generation and reinvestment capacity.
Attractive dividend yield backed by cash
A 7.53% yield signals a strong focus on returning cash to shareholders and can attract income-oriented investors. When paired with robust FCF, it suggests dividends are supported by operations rather than one-off measures, improving shareholder return durability.
Negative Factors
High financial leverage
A debt-to-equity ratio of 1.55 indicates substantial reliance on debt financing, raising interest burden and refinancing exposure. Elevated leverage limits strategic flexibility, increases vulnerability to macro shocks, and can strain cash flow allocation over the medium term.
Negative revenue trend
Declining top-line growth suggests weakening demand or loss of market share. Persistent negative revenue trends undermine economies of scale, compress future margin potential, and make sustaining investment, dividend policies and debt service more challenging over time.
Margin compression
Falling gross and net margins point to rising cost pressures or pricing challenges. Margin erosion reduces retained earnings and free cash flow, weakening the company's ability to invest, service debt, and sustain shareholder payouts absent structural fixes.

Tamar Pet (TMRP) vs. iShares MSCI Israel ETF (EIS)

Tamar Pet Business Overview & Revenue Model

Company DescriptionTamar Pet (TMRP) is a leading company in the pet care industry, specializing in the development and distribution of high-quality pet products and services. Operating across various sectors, TMRP offers a diverse range of items including premium pet food, grooming supplies, toys, and health supplements for dogs, cats, and other pets. The company is committed to enhancing the well-being of pets and their owners through innovative solutions and expert guidance.
How the Company Makes MoneyTamar Pet generates revenue through multiple streams including direct sales of pet products via e-commerce and retail partnerships, subscription services for pet food and supplies, and a range of value-added services such as grooming and training classes. Key revenue streams include the sale of high-margin proprietary pet food brands and exclusive partnerships with veterinary clinics for health products. Additionally, TMRP has established significant collaborations with pet influencers and online platforms to enhance brand visibility and drive sales, contributing to its overall earnings.

Tamar Pet Financial Statement Overview

Summary
Tamar Pet shows strong operational efficiency and cash flow generation with a cash flow score of 78. However, it faces challenges with revenue growth and high leverage, reflected in a lower balance sheet score of 65. The income statement score of 72 indicates mixed profitability and cost management.
Income Statement
72
Positive
Tamar Pet's income statement shows a mixed performance. The TTM gross profit margin is healthy at 31.99%, but has decreased from previous years, indicating pressure on cost management. The net profit margin has also declined to 16.73% TTM, suggesting reduced profitability. Revenue growth is negative at -1.83% TTM, reflecting challenges in maintaining sales momentum. However, the EBIT and EBITDA margins remain strong at 33.15% and 47.70% respectively, highlighting operational efficiency.
Balance Sheet
65
Positive
The balance sheet reveals a high debt-to-equity ratio of 1.55 TTM, indicating significant leverage which could pose financial risk. Return on equity is moderate at 12.43% TTM, showing decent profitability relative to shareholder equity. The equity ratio is low, suggesting a reliance on debt financing, which could impact financial stability in volatile market conditions.
Cash Flow
78
Positive
Cash flow analysis shows strong free cash flow growth of 38.52% TTM, indicating improved cash generation capabilities. The operating cash flow to net income ratio is 1.22, suggesting efficient cash conversion from earnings. The free cash flow to net income ratio is 0.67, reflecting a solid ability to generate cash relative to net income, supporting potential reinvestment and debt servicing.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue309.40M310.44M234.02M302.19M238.94M253.27M
Gross Profit90.67M110.27M197.19M117.71M100.27M152.47M
EBITDA211.45M157.04M144.99M158.89M131.26M194.02M
Net Income44.33M58.56M49.51M33.82M39.68M88.26M
Balance Sheet
Total Assets1.18B1.22B1.22B1.27B1.28B1.31B
Cash, Cash Equivalents and Short-Term Investments60.45M23.22M32.17M83.06M94.06M92.45M
Total Debt2.12B699.00M751.96M804.30M855.57M931.84M
Total Liabilities2.50B796.47M829.40M903.69M937.55M994.75M
Stockholders Equity1.41B427.78M392.77M362.26M346.16M313.47M
Cash Flow
Free Cash Flow151.87M89.64M47.62M161.65M136.80M168.33M
Operating Cash Flow214.36M156.18M89.70M167.76M139.21M179.45M
Investing Cash Flow58.38M-47.36M-21.74M-63.65M-4.71M-16.16M
Financing Cash Flow-221.90M-118.30M-116.20M-116.02M-133.28M-154.39M

Tamar Pet Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price4250.00
Price Trends
50DMA
3613.66
Negative
100DMA
3894.40
Negative
200DMA
3840.48
Negative
Market Momentum
MACD
-62.12
Negative
RSI
48.57
Neutral
STOCH
89.12
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IL:TMRP, the sentiment is Neutral. The current price of 4250 is above the 20-day moving average (MA) of 3409.00, above the 50-day MA of 3613.66, and above the 200-day MA of 3840.48, indicating a neutral trend. The MACD of -62.12 indicates Negative momentum. The RSI at 48.57 is Neutral, neither overbought nor oversold. The STOCH value of 89.12 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for IL:TMRP.

Tamar Pet Peers Comparison

Overall Rating
UnderperformOutperform
Sector (65)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
71
Outperform
₪24.36B15.3624.33%3.95%-15.01%-16.12%
65
Neutral
₪2.78B19.357.38%5.30%-23.48%
65
Neutral
$15.17B7.614.09%5.20%3.87%-62.32%
58
Neutral
₪16.73B4.794.49%6.64%17.71%211.99%
* Energy Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IL:TMRP
Tamar Pet
3,498.00
549.32
18.63%
IL:NWMD
Newmed Energ Pu
1,949.00
685.45
54.25%
IL:DLEKG
Delek Group
90,580.00
39,407.98
77.01%
IL:EQTL
Equital
15,090.00
-440.00
-2.83%
IL:LAPD
Lapidoth Cap.
9,640.00
1,861.70
23.93%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 18, 2025